Nov 21 (Reuters) - Zevra Therapeutics Inc :
* ZEVRA THERAPEUTICS ANNOUNCES U.S. COMMERCIAL AVAILABILITY OF MIPLYFFA™ (ARIMOCLOMOL) FOR TREATMENT OF NIEMANN-PICK DISEASE TYPE C
Source text: Further company coverage:
Nov 21 (Reuters) - Zevra Therapeutics Inc :
* ZEVRA THERAPEUTICS ANNOUNCES U.S. COMMERCIAL AVAILABILITY OF MIPLYFFA™ (ARIMOCLOMOL) FOR TREATMENT OF NIEMANN-PICK DISEASE TYPE C
Source text: Further company coverage:
Comments